Author/Authors :
Vives Corrons, Joan-Lluis Institute for Leukaemia Research Josep Carreras - ENERCA Coordinator - University of Barcelona. Catalonia (Spain) , De Sanctis, Vincenzo Pediatric and Adolescent Outpatient Clinic -Quisisana Hospital, Ferrara, Italy
Abstract :
For rare haematological diseases (RHD), the first question to be answered is if patients with be-nign red blood cell (RBC) defects like haemoglobinopathies, membranopathies and enzymopathies are more vulnerable to COVID-19 infection. Up to now, there is no yet literature on the subject, but, like in general population, the presence of comorbidities such as diabetes, heart disease, pulmonary hypertension, reduced kidney and/or liver function, worsen the effects of the infection. Splenectomy may be an additional risk factor. (www.actabiomedica.it)
